134 related articles for article (PubMed ID: 32691717)
21. Carcinogenesis mechanisms of Fusobacterium nucleatum.
Gholizadeh P; Eslami H; Kafil HS
Biomed Pharmacother; 2017 May; 89():918-925. PubMed ID: 28292019
[TBL] [Abstract][Full Text] [Related]
22. Metagenomic analysis of the fecal microbiome in colorectal cancer patients compared to healthy controls as a function of age.
Kharofa J; Apewokin S; Alenghat T; Ollberding NJ
Cancer Med; 2023 Feb; 12(3):2945-2957. PubMed ID: 36056757
[TBL] [Abstract][Full Text] [Related]
23. Utilizing Whole
Umaña A; Sanders BE; Yoo CC; Casasanta MA; Udayasuryan B; Verbridge SS; Slade DJ
J Bacteriol; 2019 Dec; 201(23):. PubMed ID: 31501282
[No Abstract] [Full Text] [Related]
24.
Li Q; Tan L; Wang H; Kou Y; Shi X; Zhang S; Pan Y
ACS Infect Dis; 2020 Jul; 6(7):1686-1696. PubMed ID: 32320601
[TBL] [Abstract][Full Text] [Related]
25. Signal peptide of FadA adhesin from Fusobacterium nucleatum plays a novel structural role by modulating the filament's length and width.
Témoin S; Wu KL; Wu V; Shoham M; Han YW
FEBS Lett; 2012 Jan; 586(1):1-6. PubMed ID: 22108653
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of FadA adhesin from Fusobacterium nucleatum reveals a novel oligomerization motif, the leucine chain.
Nithianantham S; Xu M; Yamada M; Ikegami A; Shoham M; Han YW
J Biol Chem; 2009 Feb; 284(6):3865-72. PubMed ID: 18996848
[TBL] [Abstract][Full Text] [Related]
27. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum.
Liu J; Hsieh CL; Gelincik O; Devolder B; Sei S; Zhang S; Lipkin SM; Chang YF
J Proteomics; 2019 Mar; 195():125-137. PubMed ID: 30634002
[TBL] [Abstract][Full Text] [Related]
28. Expression, Purification, and Characterization of the Recombinant, Two-Component, Response Regulator ArlR from Fusobacterium nucleatum.
Fan R; Li Z; Shi X; Wang L; Zhang X; Dong Y; Quan C
Appl Biochem Biotechnol; 2022 May; 194(5):2093-2107. PubMed ID: 35029789
[TBL] [Abstract][Full Text] [Related]
29. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
[TBL] [Abstract][Full Text] [Related]
30. The role of
Sun CH; Li BB; Wang B; Zhao J; Zhang XY; Li TT; Li WB; Tang D; Qiu MJ; Wang XC; Zhu CM; Qian ZR
Chronic Dis Transl Med; 2019 Sep; 5(3):178-187. PubMed ID: 31891129
[TBL] [Abstract][Full Text] [Related]
31. Optimized Antimicrobial Peptide Jelleine-I Derivative Br-J-I Inhibits Fusobacterium Nucleatum to Suppress Colorectal Cancer Progression.
Jia F; Yu Q; Wang R; Zhao L; Yuan F; Guo H; Shen Y; He F
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674985
[TBL] [Abstract][Full Text] [Related]
32. Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening.
Leung A; Tsoi H; Yu J
Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):651-7. PubMed ID: 25582922
[TBL] [Abstract][Full Text] [Related]
33.
Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
[TBL] [Abstract][Full Text] [Related]
34. The Fruits of
Lin LT; Shi YC; Choong CY; Tai CJ
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279421
[TBL] [Abstract][Full Text] [Related]
35. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
36. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
[TBL] [Abstract][Full Text] [Related]
37. Fusobacterium nucleatum Contributes to the Carcinogenesis of Colorectal Cancer by Inducing Inflammation and Suppressing Host Immunity.
Wu J; Li Q; Fu X
Transl Oncol; 2019 Jun; 12(6):846-851. PubMed ID: 30986689
[TBL] [Abstract][Full Text] [Related]
38. Copper(II) complexes with Fusobacterium nucleatum adhesin FadA: Coordination pattern, physicochemical properties and reactivity.
Krupa K; Lesiów M; Stokowa-Sołtys K; Starosta R; Ptaszyńska N; Łęgowska A; Rolka K; Wernecki M; Cal M; Jeżowska-Bojczuk M
J Inorg Biochem; 2018 Dec; 189():69-80. PubMed ID: 30243120
[TBL] [Abstract][Full Text] [Related]
39. Fusobacterium nucleatum aggravates rheumatoid arthritis through FadA-containing outer membrane vesicles.
Hong M; Li Z; Liu H; Zheng S; Zhang F; Zhu J; Shi H; Ye H; Chou Z; Gao L; Diao J; Zhang Y; Zhang D; Chen S; Zhou H; Li J
Cell Host Microbe; 2023 May; 31(5):798-810.e7. PubMed ID: 37054714
[TBL] [Abstract][Full Text] [Related]
40. RETRACTED: Comparison between diagnostic performance of intestinal Fusobacterium nucleatum, Bacteroides fragilis and Escherichia coli in 5-fluorouracil resistance to colorectal cancer: A meta‑analysis.
Wang WY; Zhou H; Wang Z; Zhang YH
Cancer Treat Res Commun; 2022; 32():100536. PubMed ID: 35567912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
